Quantifying stakeholders’ preference for implantable medical devices in China: a discrete choice experiment

Author:

Wan Bin,Shen Jiaojie,Chen Jiali,Weng Linjia,Zhao Peng,Deng Yunfei,Zhang LingliORCID,Zhang Feiyi,Wang Yingpeng,Li Xin,Chang Feng,Ding Haixia,Lu YunORCID

Abstract

Abstract Objectives This study aims to gain insight into each attribute as presented in the value of implantable medical devices, quantify attributes’ strength and their relative importance, and identify the determinants of stakeholders’ preferences. Methods A mixed-methods design was used to identify attributes and levels reflecting stakeholders’ preference toward the value of implantable medical devices. This design combined literature reviewing, expert’s consultation, one-on-one interactions with stakeholders, and a pilot testing. Based on the design, six attributes and their levels were settled. Among 144 hypothetical profiles, 30 optimal choice sets were developed, and healthcare professionals (decision-makers, health technology assessment experts, hospital administrators, medical doctors) and patients as stakeholders in China were surveyed. A total of 134 respondents participated in the survey. Results were analyzed by mixed logit model and conditional logit model. Results The results of the mixed logit model showed that all the six attributes had a significant impact on respondents’ choices on implantable medical devices. Respondents were willing to pay the highest for medical devices that provided improvements in clinical safety, followed by increased clinical effectiveness, technology for treating severe diseases, improved implement capacity, and innovative technology (without substitutes). Conclusions The findings of DCE will improve the current evaluation on the value of implantable medical devices in China and provide decision-makers with the relative importance of the criteria in pricing and reimbursement decision-making of implantable medical devices.

Publisher

Cambridge University Press (CUP)

Reference24 articles.

1. Eliciting preferences for medical devices in South Korea: A discrete choice experiment;Lee;Health Policy.,2017

2. 21. National Medical Product Administration. The First BOao International Pharmaceutical and Mecial Devices Real-world Research Conference. 2022. Available from: https://www.nmpa.gov.cn/yaowen/ypjgyw/hyxx/20221208194613172.html (accessed August 10, 2023).

3. Discrete choice experiments in health economics: A review of the literature;de Bekker-Grob;Health Econ.,2012

4. 4. National Healthcare Security Administration. The National Medical Insurance Bureau officially launched the three-year action plan for DRG/DIP payment reform. 2021. Available from: http://www.nhsa.gov.cn/art/2021/11/26/art_104_7413.html (accessed August 10, 2023).

5. Establishment of multi-criteria value assessment index system for medical consumables;Huangying;China Health Insur.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3